Ingredient Guide
Rhodiola Rosea: Benefits, Dosage, and What the Research Says
The adaptogen with decades of clinical research behind it - and honest limits you should know about.
Written by Jessica Medson
Rhodiola rosea - also called golden root or arctic root - is a flowering plant from high-altitude regions of Europe and Asia whose roots contain two key active classes: rosavins and salidroside. Clinical research suggests it may help maintain mental performance and reduce stress-related fatigue, with one placebo-controlled trial finding that 576 mg daily significantly reduced burnout scores and cortisol awakening response compared to placebo. Evidence also extends to exercise endurance, with a 2025 meta-analysis of 26 randomized trials reporting significant improvements in VO2max and time to exhaustion at standard supplemental doses.
What Is Rhodiola Rosea?
Rhodiola rosea - known in traditional medicine as golden root or arctic root - is a flowering perennial plant native to the cold, high-altitude regions of Europe and Asia, including Scandinavia, Siberia, the Carpathian Mountains, and the Tibetan plateau. For centuries, Russian, Scandinavian, and Chinese traditional medicine practitioners used its roots to support energy, endurance, and resistance to harsh environmental conditions.1
Scientific research has identified more than 140 bioactive compounds in the root and rhizome. Two classes are considered the most pharmacologically significant:1
- Rosavins (rosavin, rosarin, and rosin): Phenylpropanoid glycosides found almost exclusively in Rhodiola rosea among all Rhodiola species. Commercial extracts are standardized to at least 3% rosavins.
- Salidroside (p-tyrosol glucoside): A phenylethanol glycoside with well-studied antioxidant and adaptogenic properties. Standardized extracts typically contain 1% salidroside.
The 3:1 ratio of rosavins to salidroside reflects the natural proportion in wild-harvested root. Products using non-standardized Rhodiola powder may deliver inconsistent amounts of these key compounds, making standardization an important quality marker when selecting a supplement.
Rhodiola is classified as an adaptogen - a category describing botanicals that may help the body maintain physiological homeostasis under physical or psychological stress without producing sedation or significant dependency risk. This classification describes a pharmacological pattern observed across multiple studies, not a drug claim.2
How Does It Work? The Adaptogenic Mechanism
Rhodiola rosea appears to act on several intersecting biological pathways, which may explain the range of effects reported across clinical trials.
HPA axis modulation
The hypothalamic-pituitary-adrenal (HPA) axis governs the body's primary stress-response cascade. Research suggests that salidroside may dampen excessive HPA activation, reducing downstream cortisol output during acute stress. In a placebo-controlled trial, participants taking 576 mg of standardized Rhodiola extract daily showed a significantly blunted cortisol awakening response compared to placebo - a validated proxy for chronic stress load.3
Monoamine neurotransmitter support
Rosavins appear to inhibit monoamine oxidase (MAO), the enzyme responsible for breaking down dopamine, serotonin, and norepinephrine in the brain. By slowing this degradation, Rhodiola may help sustain neurotransmitter availability in circuits involved in mood, attention, and motivation.1 This same MAO-inhibiting activity also underpins the most important drug interaction risk discussed in the safety section below.
Antioxidant and cytoprotective effects
A 2025 meta-analysis of 26 randomized trials found that Rhodiola supplementation significantly increased superoxide dismutase (SOD) activity (effect size 1.16) and total antioxidant capacity while reducing malondialdehyde - a marker of lipid peroxidation and oxidative damage.12 These effects may partly explain Rhodiola's observed benefits on post-exercise recovery.
Heat shock proteins and nitric oxide signaling
Preclinical data suggest that Rhodiola compounds activate heat shock proteins and nitric oxide signaling pathways that help cells resist heat, hypoxia, and toxin-induced damage.1 These mechanisms are biologically plausible but have not been directly confirmed in human trials - they remain Tier C (preclinical) evidence at this time.
Stress-Related Fatigue and Burnout: The Strongest Evidence
The most consistent clinical evidence for Rhodiola rosea centers on stress-related and mental fatigue - a pattern of exhaustion tied to sustained cognitive demands rather than acute physical exertion. This is the area where the most rigorously designed trials have been conducted.
What the research shows
A double-blind, crossover study enrolled 56 young physicians working night shifts and found that a standardized SHR-5 extract produced statistically significant improvements in associative thinking, short-term memory, calculation speed, and audio-visual perception compared to placebo over a two-week treatment period. No adverse effects were recorded.4
In a separate double-blind pilot study of students during exam periods, those receiving Rhodiola extract showed significant improvements in physical fitness, mental fatigue, and neuro-motor performance (p less than 0.01) versus placebo, alongside better general well-being scores (p less than 0.05).5
A randomized, parallel-group, placebo-controlled trial enrolled 60 adults with burnout-related stress-related fatigue. Participants taking 576 mg of SHR-5 daily showed significant improvements on the Pines' Burnout Scale and attention indices compared to placebo, alongside a meaningfully reduced cortisol awakening response.3
A multicenter open-label trial with 118 outpatients meeting criteria for burnout syndrome administered 400 mg of Rhodiola extract daily for 12 weeks. Improvements were observed across emotional exhaustion, depersonalization, and overall functional impairment ratings. Importantly, 41.9% of participants achieved marked improvement on clinical global impression scores, and the adverse event rate was very low at 0.015 events per observation day.7
Honest interpretation
A 2012 systematic review that examined 11 eligible studies - 10 of which were RCTs - concluded that while some evidence supports Rhodiola for both physical and mental fatigue, "methodological flaws limit accurate assessment of efficacy" and called for more rigorous research.6 A 2022 narrative review took a more optimistic stance, concluding that the collective clinical data provides "an encouraging basis" for Rhodiola's use in managing stress-induced conditions.2
Bottom line: Stress-related and mental fatigue is where Rhodiola has the most human trial support. Effects appear meaningful in the studied populations, but design limitations in several trials mean high certainty cannot yet be claimed.
Cognitive Performance and Mental Clarity
Several clinical studies have examined whether Rhodiola rosea may help maintain measurable cognitive function under demanding conditions, separately from subjective fatigue ratings.
What the research shows
The night-duty physician trial discussed in the fatigue section directly measured multiple cognitive domains - associative thinking, memory, and calculation - and found significant improvements over placebo during stress-intensive working conditions.4 These objective improvements alongside subjective fatigue relief are a meaningful feature of that study.
A more recent 12-week single-arm pilot study enrolled 50 adults taking 2 x 200 mg of Rhodiola extract (Rosalin WS 1,375) daily. Participants showed improved reaction times across three separate attention paradigms - the attention network task, go/no-go task, and divided attention task - alongside increased P3 brain potential amplitude, a neurophysiological marker associated with enhanced cognitive resource allocation. The authors noted these findings require replication in a placebo-controlled design before firm conclusions can be drawn.8
Important caveats
Not all cognitive outcomes have been positive. One 14-day study in 80 mildly anxious adults found no significant differences between Rhodiola and a control condition on objective cognitive test performance, despite significant improvements in mood and subjective stress.9 The cognitive data overall is suggestive but inconsistent. Benefits appear most likely during conditions of acute stress or fatigue rather than as a broad cognitive enhancer in well-rested individuals.
Mood, Anxiety, and Emotional Well-Being
Research has explored Rhodiola rosea's potential role in supporting mood and managing stress-related emotional symptoms. This area shows clinically meaningful signals but requires careful interpretation - particularly because effect sizes have been modest and sample sizes small.
What the research shows
A controlled trial assigned 80 mildly anxious participants to Rhodiola (2 x 200 mg daily) or a control condition for 14 days. The Rhodiola group showed significant reductions in self-reported anxiety, stress, anger, confusion, and depression, along with measurable mood improvement. Because this study lacked a placebo arm, the findings are rated as Tier B (human observational/active-controlled) evidence.9
A randomized, double-blind, placebo-controlled trial in 89 patients aged 18-70 with mild-to-moderate depression found that both 340 mg and 680 mg daily of SHR-5 extract produced statistically significant improvements in total Hamilton Rating Scale for Depression (HAM-D) scores and Beck Depression Inventory (BDI) scores after six weeks, with no serious adverse events reported in any group.10
A three-arm proof-of-concept trial compared Rhodiola rosea, sertraline (an SSRI), and placebo over 12 weeks in 57 adults with mild-to-moderate major depressive disorder. Sertraline produced greater symptom reduction (HAM-D decline of -8.2 points), but differences between all three groups were not statistically significant (p = 0.79). However, Rhodiola caused adverse events in only 30% of participants versus 63% for sertraline, leading the authors to suggest it "may possess a more favorable risk-to-benefit ratio" for mild presentations - an interesting finding from a small feasibility trial.11
Honest framing
The mood data is intriguing but not definitive. Individual trials show promising signals, yet sample sizes are small and at least one large comparison found no statistically significant difference between Rhodiola and placebo on primary outcomes. Individuals managing clinically significant depression or anxiety should discuss all options with a qualified healthcare provider. Rhodiola is not a replacement for established treatments.
Exercise Endurance and Physical Recovery
A growing and relatively rigorous body of research has examined whether Rhodiola rosea supplementation may support athletic endurance and reduce markers of exercise-induced physiological stress.
What the research shows
A 2025 systematic review and meta-analysis pooled data from 26 randomized controlled trials involving 668 healthy participants (mean age 22 years). Rhodiola supplementation was associated with statistically significant improvements in:12
- VO2max: Effect size 0.32 (p less than 0.01)
- Time to exhaustion: Effect size 0.38 (p less than 0.05)
- Time trial performance: Effect size -0.40 favoring Rhodiola (p less than 0.05)
- Blood lactate: Effect size -0.87, suggesting improved metabolic efficiency
- Creatine kinase: Effect size -0.84, indicating reduced muscle damage markers
On the antioxidant side, superoxide dismutase increased (ES 1.16), malondialdehyde decreased (ES -1.21), and total antioxidant capacity improved (ES 0.59). No significant effects were observed on inflammatory markers, including interleukin-6 or C-reactive protein.12
A subgroup analysis in the same meta-analysis suggested greater VO2max benefit at doses exceeding 600 mg per day, though this finding needs prospective confirmation.
Putting it in context
With 26 RCTs and 668 participants, this is one of the larger evidence datasets in the Rhodiola literature. That said, participants were predominantly young adults, and whether these endurance effects translate to recreational exercisers, older populations, or team-sport athletes is not yet established. Effect sizes in the small-to-moderate range suggest real but not dramatic benefits alongside a structured training program.
Safety, Side Effects, and Drug Interactions
Rhodiola rosea is generally well-tolerated at standard doses in clinical trials, but several safety considerations require specific attention before beginning supplementation.
Common side effects
- Insomnia or vivid dreams if taken in the afternoon or evening - the most frequently reported complaint across trials; resolved by moving dosing to the morning
- Dizziness and dry mouth - reported in approximately 30% of participants in one trial11
- Irritability or restlessness at higher doses (above 500-600 mg), particularly in individuals sensitive to stimulant-like effects
- In the largest open-label burnout trial (400 mg daily, 118 participants, 12 weeks), adverse events occurred at a very low rate of 0.015 per observation day7
Drug interactions - important
Because rosavins inhibit monoamine oxidase (MAO), combining Rhodiola with medications that increase serotonin activity - including SSRIs (fluoxetine, sertraline, paroxetine), SNRIs, or MAO inhibitors - may increase the risk of serotonergic side effects or, in severe cases, serotonin syndrome. A published case report described a 68-year-old woman with depression who developed vegetative symptoms, restlessness, and trembling consistent with serotonin syndrome after self-administering Rhodiola extract alongside prescribed paroxetine. The authors attributed this to a pharmacodynamic herb-drug interaction.13
Additional interactions to discuss with your healthcare provider:
- Anticoagulants (e.g., warfarin): Possible CYP pathway interactions; INR monitoring recommended
- Antihypertensives: Additive blood-pressure-lowering effects are theoretically possible at higher doses
- Antidiabetic medications: Salidroside may influence glucose regulation; monitor blood sugar
- Stimulants: Additive stimulant-like effects are possible at doses above 500 mg
Who should avoid use or exercise extra caution
- Pregnancy and breastfeeding: Insufficient human safety data exist. Avoid unless directed by a qualified healthcare provider.
- Bipolar disorder: MAO-inhibiting activity raises theoretical concerns about mood switching; consult a psychiatrist before using.
- Pre-surgery: Discontinue at least two weeks before elective surgery due to potential interactions with anesthetic and blood-thinning agents.
- Children and adolescents: No safety data in pediatric populations; not recommended.
Always disclose Rhodiola use to your healthcare provider, especially if you take prescription medications for mood, blood pressure, diabetes, or blood thinning.
Rhodiola Rosea Dosage Guide
The following doses are drawn from published clinical trials using standardized extract (3% rosavins, 1% salidroside), most commonly the SHR-5 extract. These doses apply to adults only. Start at the lower end of any range to assess individual tolerance before increasing. All doses should be taken with food.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| Stress-related and mental fatigue | 200-576 mg daily | Morning, with food | 576 mg SHR-5 reduced Pines' Burnout Scale scores and blunted cortisol awakening response versus placebo in a 60-person RCT |
| Burnout symptom support | 400 mg daily | Morning, for a minimum of 12 weeks | Used in a 118-patient multicenter open-label trial; 41.9% achieved marked improvement on clinical global impression ratings |
| Mood and mild depression symptom support | 340-680 mg daily | Morning, with food | Both doses produced significant HAM-D and BDI improvements in a 6-week placebo-controlled RCT (89 participants, ages 18-70); no serious adverse events at either dose |
| Mild anxiety and stress symptoms | 400 mg daily (2 x 200 mg) | Morning and midday | 14-day trial in 80 mildly anxious adults showed significant reductions in self-reported anxiety, stress, anger, and confusion |
| Exercise endurance and recovery | 400-600+ mg daily | 30-60 minutes before training | Meta-analysis of 26 RCTs (668 participants) found significant improvements in VO2max and time to exhaustion; subgroup analysis suggests greater VO2max benefit at doses above 600 mg/day |
Do not take Rhodiola in the evening - the majority of clinical trials dosed it in the morning or split between morning and midday to avoid insomnia. If you are taking any prescription medication, especially antidepressants, blood thinners, or antihypertensives, consult a healthcare provider before starting.
What the Evidence Shows at a Glance
This table summarizes the state of the clinical evidence for each area of study as of 2025. Effect sizes and trial counts reflect the most rigorous published data available.
| Outcome | Evidence Level | Key Finding | Overall Strength |
|---|---|---|---|
| Mental fatigue under stress (physicians, students) | Tier A: Multiple placebo-controlled RCTs | Significant improvements in cognitive test scores and subjective fatigue during high-demand periods at 200-576 mg/day | Moderate - best-supported use case; 2012 systematic review noted methodological limitations in several trials |
| Burnout symptom reduction | Tier A (RCTs) + Tier B (open-label) | Reduced Pines' Burnout Scale and cortisol awakening response; 41.9% marked improvement in open-label cohort at 400 mg/day | Moderate - consistent direction of effect across study designs |
| Cognitive attention (healthy adults) | Tier B: Single-arm pilot study | Faster reaction times and increased P3 brain potential amplitude at 400 mg/day over 12 weeks (n=50) | Low to moderate - promising signal; placebo-controlled replication needed |
| Anxiety and stress symptoms | Tier B: Active-controlled (no placebo) | Significant reductions in anxiety, stress, anger, and confusion at 400 mg/day over 14 days (n=80) | Low to moderate - absence of placebo arm limits causal inference |
| Mild-to-moderate depression symptoms | Tier A: Two RCTs | Significant HAM-D improvements at 340-680 mg/day in one RCT; modest, non-significant improvements vs. sertraline and placebo in a second RCT | Low to moderate - mixed primary outcomes; small samples (57-89 participants) |
| Exercise endurance and physical recovery | Tier A: Meta-analysis of 26 RCTs (668 participants) | VO2max ES +0.32; time to exhaustion ES +0.38; blood lactate and creatine kinase significantly reduced | Moderate to good - largest dataset for Rhodiola; predominantly young adult samples |
Tier A = human RCT or meta-analysis; Tier B = human observational, open-label, or active-controlled study; ES = effect size (Cohen's d). Strength ratings reflect both study quality and consistency of findings across trials.
Frequently Asked Questions
What is Rhodiola Rosea good for?
Rhodiola rosea has the strongest clinical support for stress-related mental fatigue and burnout, with multiple placebo-controlled trials showing improvements in cognitive performance and fatigue scores under demanding conditions. Research also suggests potential benefits for exercise endurance, mild anxiety, and mood, though evidence in those areas is more limited in scope and sample size.
How much Rhodiola Rosea should I take?
Clinical trials have used doses ranging from 200 mg to 680 mg of standardized extract (3% rosavins, 1% salidroside) daily. Most trials dosed between 340 and 576 mg per day for fatigue and mood. A 2025 meta-analysis on exercise performance suggested greater VO2max benefits at doses above 600 mg/day. Start at the lower end and assess tolerance.
How long does Rhodiola Rosea take to work?
In the burnout trial, improvements were observed on several measures within the first week at 400 mg daily. For more robust effects, most trials ran 6 to 12 weeks. Exercise performance benefits in the meta-analysis also appeared with supplementation periods extending beyond four weeks, suggesting some benefit accrues over time.
Is Rhodiola Rosea safe?
At standard doses (200-600 mg daily), Rhodiola is generally well-tolerated. In one 12-week trial of 118 participants, adverse events occurred at just 0.015 per observation day. The most common complaints are insomnia if taken in the evening, dizziness, and dry mouth. It should not be combined with serotonergic antidepressants without medical supervision due to a reported drug interaction risk.
Does Rhodiola Rosea work for anxiety?
A 14-day active-controlled trial in 80 mildly anxious adults found significant reductions in self-reported anxiety, stress, anger, confusion, and depression with 400 mg daily. However, because the trial lacked a placebo arm, causal conclusions are limited. A small 10-week open-label pilot in 10 participants with generalized anxiety disorder also found significant HARS score reductions.
Does Rhodiola Rosea interact with antidepressants?
Yes - this is the most important safety consideration. Rhodiola rosavins inhibit monoamine oxidase (MAO), potentially increasing serotonin levels. A published case report documented serotonin syndrome symptoms (restlessness, trembling, and vegetative syndrome) in a woman combining Rhodiola with the SSRI paroxetine. Do not combine Rhodiola with SSRIs, SNRIs, or MAO inhibitors without discussing it with your doctor first.
What are the side effects of Rhodiola Rosea?
The most commonly reported side effects are insomnia or vivid dreams (especially with evening dosing), dizziness, and dry mouth. In the sertraline comparison trial, 30% of Rhodiola users reported adverse events versus 63% for sertraline. Irritability or restlessness can occur at doses above 500-600 mg daily. Taking Rhodiola in the morning with food reduces most side effect risk.
Can I take Rhodiola Rosea every day?
Clinical trials have administered Rhodiola daily for periods ranging from 14 days to 12 weeks without significant safety concerns at standard doses. No formal long-term safety studies beyond 12 weeks have been published. Some practitioners suggest cycling use (e.g., 8-12 weeks on, 2-4 weeks off), though this practice is not validated by clinical trial evidence.
What is the best time of day to take Rhodiola Rosea?
Morning is strongly preferred. Rhodiola has mild stimulant-like properties at standard doses, and nearly all clinical trials administered it in the morning or split doses across morning and midday. Taking it in the afternoon or evening is associated with the most frequently reported side effect: difficulty falling asleep or unusually vivid dreams.
Does Rhodiola Rosea help with exercise performance?
Research suggests it may. A 2025 meta-analysis of 26 randomized trials and 668 healthy participants found that Rhodiola supplementation produced a small but statistically significant improvement in VO2max (effect size 0.32), time to exhaustion (effect size 0.38), and post-exercise lactate and creatine kinase levels. Most participants in these trials were young adults, so generalizability to older or recreational populations is uncertain.
Shop Rhodiola Rosea
HealthFare Rhodiola Rosea supplements
Scientific References
- 1.Panossian A, Wikman G, Sarris J Rosenroot (Rhodiola rosea): traditional use, chemical composition, pharmacology and clinical efficacy. Phytomedicine. 2010. PubMed: 20378318Human observational
- 2.Stojcheva EI, Quintela JC The Effectiveness of Rhodiola rosea L. Preparations in Alleviating Various Aspects of Life-Stress Symptoms and Stress-Induced Conditions - Encouraging Clinical Evidence. Molecules. 2022. PubMed: 35745023Human observational
- 3.Olsson EM, von Scheele B, Panossian AG A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica. 2009. PubMed: 19016404Clinical (RCT / meta-analysis)
- 4.Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000. PubMed: 11081987Clinical (RCT / meta-analysis)
- 5.Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 2000. PubMed: 10839209Clinical (RCT / meta-analysis)
- 6.Ishaque S, Shamseer L, Bukutu C, Vohra S Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complementary and Alternative Medicine. 2012. PubMed: 22643043Clinical (RCT / meta-analysis)
- 7.Kasper S, Dienel A Multicenter, open-label, exploratory clinical trial with Rhodiola rosea extract in patients suffering from burnout symptoms. Neuropsychiatric Disease and Treatment. 2017. PubMed: 28367055Human observational
- 8.Koop T, Dienel A, Heldmann M, Munte TF Effects of a Rhodiola rosea extract on mental resource allocation and attention: an event-related potential dual task study. Phytotherapy Research. 2020. PubMed: 32592534Human observational
- 9.Cropley M, Banks AP, Boyle J The Effects of Rhodiola rosea L. Extract on Anxiety, Stress, Cognition and Other Mood Symptoms. Phytotherapy Research. 2015. PubMed: 26502953Human observational
- 10.Darbinyan V, Aslanyan G, Amroyan E, Gabrielyan E, Malmstrom C, Panossian A Clinical trial of Rhodiola rosea L. extract SHR-5 in the treatment of mild to moderate depression. Nordic Journal of Psychiatry. 2007. PubMed: 17990195Clinical (RCT / meta-analysis)
- 11.Mao JJ, Xie SX, Zee J, Soeller I, Li QS, Rockwell K, Amsterdam JD Rhodiola rosea versus sertraline for major depressive disorder: a randomized placebo-controlled trial. Phytomedicine. 2015. PubMed: 25837277Clinical (RCT / meta-analysis)
- 12.Wang X, Yang X, Gao Z, Zeng J, Liu Y The effect of Rhodiola rosea supplementation on endurance performance and related biomarkers: a systematic review and meta-analysis. Frontiers in Nutrition. 2025. PubMed: 41080184Clinical (RCT / meta-analysis)
- 13.Maniscalco I, Toffol E, Giupponi G, Conca A The interaction of Rhodiola rosea and antidepressants. A case report. Neuropsychiatrie. 2015. PubMed: 25413939Preclinical (animal / cell)